Pharmaceutical

AION Labs and BioMed X launch sixth challenge for AI-dr...

The startup will utilise cutting edge methods to accelerate drug discovery resea...

Catalent CEO drops FY2023 revenue forecast by $450m aft...

In an investor call on 19 May, Catalent reduced its annual net revenue forecast ...

Abiogen acquires EffRx to fortify bone disease portfolio

The Italian pharmaceutical company Abiogen Pharma acquired Effrx Pharmaceuticals...

AstriVax received €2.5 million government grant for the...

The Flemish government grant adds on past seed funding that will be used to move...

SK Bioscience gains UK authorisation for SKYCovion Covi...

SKYCovion was created in collaboration with GSK's pandemic adjuvant and is suita...

Opinion: More young people should be getting their chol...

National guidelines around screening and treating cholesterol in young adults ne...

STAT+: Omada tackles obesity drugs, Boston Scientific n...

In the latest edition of STAT's Health Tech newsletter: Omada tackles obesity dr...

STAT+: Will Medicare cover it? Drugs like Aduhelm are c...

Medicare’s coverage decision has revived longstanding questions about how the fe...

Who’s acquiring who? Virtual care M&A activity in the p...

Analysis of the key themes driving M&A activity reveals that virtual care accoun...

Who’s acquiring who? Immuno-oncology M&A activity in th...

Analysis of the key themes driving M&A activity reveals that immuno-oncology acc...

Who’s acquiring who? Orphan designated drugs M&A activi...

Analysis of the key themes driving M&A activity reveals that orphan designated d...

STAT+: Neuralink can now study its brain implant in hum...

Neuralink, however closely watched, is still catching up to its peers in the neu...

Omada tackles obesity drugs, Boston Scientific nixes de...

In the latest edition of STAT's Health Tech newsletter: Omada tackles obesity dr...

Some hoped a new oral vaccine would solve all the polio...

Millions of doses into the rollout of a new polio vaccine, it is apparent that t...

STAT+: Pharmalittle: EMA urges revoking authorization f...

The European Medicines Agency recommended revoking marketing authorization for a...

Science finally figured out how to make effective RSV v...

A host of hurdles threaten to hinder the use of newly developed RSV vaccines for...